GlobeNewswire: Bavarian Nordic A/S Contains the last 10 of 1702 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T17:19:32ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/21/2850103/0/en/Bavarian-Nordic-A-S-Notice-Convening-Annual-General-Meeting.html?f=22&fvtc=4&fvtv=30359Bavarian Nordic A/S – Notice Convening Annual General Meeting2024-03-21T11:00:00Z<![CDATA[COPENHAGEN, Denmark, March 21, 2024 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the Annual General Meeting to be held on]]>https://www.globenewswire.com/news-release/2024/03/21/2850103/0/da/Bavarian-Nordic-A-S-Indkaldelse-til-ordin%C3%A6r-generalforsamling.html?f=22&fvtc=4&fvtv=30359Bavarian Nordic A/S - Indkaldelse til ordinær generalforsamling2024-03-21T11:00:00Z<![CDATA[KØBENHAVN, Danmark, 21. marts 2024 – I overensstemmelse med vedtægternes §§ 10-14 indkaldes herved til ordinær generalforsamling i Bavarian Nordic A/S:]]>https://www.globenewswire.com/news-release/2024/03/13/2845416/0/en/Bavarian-Nordic-Receives-Approval-of-Smallpox-and-Mpox-Vaccine-in-Switzerland.html?f=22&fvtc=4&fvtv=30359Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in Switzerland2024-03-13T12:29:21Z<![CDATA[COPENHAGEN, Denmark, March 13, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS® (MVA-BN) for active immunization against disease caused by smallpox, mpox and vaccinia viruses in adults 18 years of age and older.]]>https://www.globenewswire.com/news-release/2024/03/13/2845416/0/da/Bavarian-Nordics-mpox-og-koppevaccine-opn%C3%A5r-godkendelse-i-Schweiz.html?f=22&fvtc=4&fvtv=30359Bavarian Nordics mpox- og koppevaccine opnår godkendelse i Schweiz 2024-03-13T12:29:21Z<![CDATA[KØBENHAVN, Danmark, 13. marts 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at lægemiddelmyndighederne i Schweiz, Swissmedic, har godkendt JYNNEOS® (MVA-BN) til aktiv immunisering mod sygdom forårsaget af kopper, mpox og vacciniavirus hos voksne i alderen 18 år og opefter.]]>https://www.globenewswire.com/news-release/2024/03/12/2844822/0/en/Report-of-transactions-of-shares-and-related-securities-of-Bavarian-Nordic-by-persons-holding-managerial-responsibilities-and-or-persons-companies-closely-associated-with-such.html?f=22&fvtc=4&fvtv=30359Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such2024-03-12T16:30:00Z<![CDATA[COPENHAGEN, Denmark, March 12, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.]]>https://www.globenewswire.com/news-release/2024/03/12/2844822/0/da/Indberetning-af-ledende-medarbejdere-og-disses-n%C3%A6rtst%C3%A5endes-transaktioner-med-Bavarian-Nordic-aktier-og-tilknyttede-v%C3%A6rdipapirer.html?f=22&fvtc=4&fvtv=30359Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer 2024-03-12T16:30:00Z<![CDATA[KØBENHAVN, Danmark, 12. marts 2024 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse, hvilke hermed offentliggøres i overensstemmelse med §19 i Europa Parlamentets og Rådets forordning (EU) nr. 596/2014 samt Kommissionens Gennemførelsesforordning (EU) nr. 2016/523.]]>https://www.globenewswire.com/news-release/2024/03/06/2841053/0/en/Report-of-transactions-of-shares-and-related-securities-of-Bavarian-Nordic-by-persons-holding-managerial-responsibilities-and-or-persons-companies-closely-associated-with-such.html?f=22&fvtc=4&fvtv=30359Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such2024-03-06T06:50:00Z<![CDATA[COPENHAGEN, Denmark, March 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.]]>https://www.globenewswire.com/news-release/2024/03/06/2841053/0/da/Indberetning-af-ledende-medarbejdere-og-disses-n%C3%A6rtst%C3%A5endes-transaktioner-med-Bavarian-Nordic-aktier-og-tilknyttede-v%C3%A6rdipapirer.html?f=22&fvtc=4&fvtv=30359Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer 2024-03-06T06:50:00Z<![CDATA[KØBENHAVN, Danmark, 6. marts 2024 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende medarbejdere og/eller personer/firmaer der er nærtstående til disse, hvilke hermed offentliggøres i overensstemmelse med §19 i Europa Parlamentets og Rådets forordning (EU) nr. 596/2014 samt Kommissionens Gennemførelsesforordning (EU) nr. 2016/523.]]>https://www.globenewswire.com/news-release/2024/03/06/2841051/0/en/Bavarian-Nordic-Publishes-Annual-Report-2023.html?f=22&fvtc=4&fvtv=30359Bavarian Nordic Publishes Annual Report 20232024-03-06T06:38:05Z<![CDATA[COPENHAGEN, Denmark, March 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) today published its Annual Report for 2023. The consolidated, audited results were in line with the preliminary results, announced on February 21, 2024, and exceeded prior guidance. The full report is attached as a PDF file and can be found on the Company's website, www.bavarian-nordic.com.]]>https://www.globenewswire.com/news-release/2024/03/06/2841051/0/da/Bavarian-Nordic-offentligg%C3%B8r-%C3%A5rsrapport-for-2023.html?f=22&fvtc=4&fvtv=30359Bavarian Nordic offentliggør årsrapport for 20232024-03-06T06:38:05Z<![CDATA[KØBENHAVN, Danmark, 6. marts 2024 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag årsrapporten for 2023. De konsoliderede og reviderede finansielle resultater var i overensstemmelse med de foreløbige resultater, der blev udsendt den 21. februar 2024, og som oversteg de tidligere forventninger. Den fuldstændige rapport er vedhæftet som pdf-fil og kan desuden findes på selskabets hjemmeside www.bavarian-nordic.com.]]>